FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1268508004: Product containing precisely leuprorelin (as leuprorelin acetate) 5 milligram/1 each prolonged-release subcutaneous implant (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5179995011 Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5179996012 Product containing precisely leuprorelin (as leuprorelin acetate) 5 milligram/1 each prolonged-release subcutaneous implant (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5179997015 Leuprolide (as leuprolide acetate) 5 mg prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5179995011 Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5179996012 Product containing precisely leuprorelin (as leuprorelin acetate) 5 milligram/1 each prolonged-release subcutaneous implant (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5179997015 Leuprolide (as leuprolide acetate) 5 mg prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Is a Product containing only leuprorelin in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has manufactured dose form Prolonged-release subcutaneous implant true Inferred relationship Existential restriction modifier (core metadata concept)
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has unit of presentation Implant (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has precise active ingredient Leuprorelin acetate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has basis of strength substance (attribute) Leuprorelin true Inferred relationship Existential restriction modifier (core metadata concept) 1
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has presentation strength denominator unit (attribute) Implant (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start